[go: up one dir, main page]

MX2018014532A - Un metodo para reducir la contaminacion de los huevos. - Google Patents

Un metodo para reducir la contaminacion de los huevos.

Info

Publication number
MX2018014532A
MX2018014532A MX2018014532A MX2018014532A MX2018014532A MX 2018014532 A MX2018014532 A MX 2018014532A MX 2018014532 A MX2018014532 A MX 2018014532A MX 2018014532 A MX2018014532 A MX 2018014532A MX 2018014532 A MX2018014532 A MX 2018014532A
Authority
MX
Mexico
Prior art keywords
reducing egg
egg contamination
contamination
reducing
salmonella
Prior art date
Application number
MX2018014532A
Other languages
English (en)
Inventor
Ducatelle Richard
Van Immerseel Filip
Raspoet Ruth
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of MX2018014532A publication Critical patent/MX2018014532A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a cepas mutantes de Salmonella y a su uso como una vacuna para prevenir la infección por Salmonella, en particular en huevos.
MX2018014532A 2016-05-26 2017-05-23 Un metodo para reducir la contaminacion de los huevos. MX2018014532A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16171540 2016-05-26
PCT/EP2017/062330 WO2017202804A1 (en) 2016-05-26 2017-05-23 A method of reducing egg contamination

Publications (1)

Publication Number Publication Date
MX2018014532A true MX2018014532A (es) 2019-05-20

Family

ID=56116217

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014532A MX2018014532A (es) 2016-05-26 2017-05-23 Un metodo para reducir la contaminacion de los huevos.

Country Status (9)

Country Link
US (2) US10842861B2 (es)
EP (1) EP3463442A1 (es)
CN (1) CN109496156A (es)
BR (1) BR112018074107A2 (es)
CA (1) CA3025410A1 (es)
MX (1) MX2018014532A (es)
PE (1) PE20190225A1 (es)
RU (1) RU2018145441A (es)
WO (1) WO2017202804A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3025410A1 (en) * 2016-05-26 2017-11-30 Universiteit Gent A method of reducing egg contamination
CN114532295B (zh) * 2022-03-19 2024-04-16 广西参皇养殖集团有限公司 一种优质鸡育种核心群白血病与鸡白痢联合净化的方法
CN114854654B (zh) * 2022-04-06 2023-12-15 青岛易邦生物工程有限公司 一种肠炎沙门氏菌活疫苗

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0511203D0 (en) * 2005-06-02 2005-07-06 Univ Birmingham Vaccines
CA3025410A1 (en) * 2016-05-26 2017-11-30 Universiteit Gent A method of reducing egg contamination

Also Published As

Publication number Publication date
RU2018145441A (ru) 2020-06-26
EP3463442A1 (en) 2019-04-10
WO2017202804A1 (en) 2017-11-30
US20210145954A1 (en) 2021-05-20
US20190192647A1 (en) 2019-06-27
CN109496156A (zh) 2019-03-19
US10842861B2 (en) 2020-11-24
BR112018074107A2 (pt) 2019-03-06
RU2018145441A3 (es) 2020-08-21
CA3025410A1 (en) 2017-11-30
PE20190225A1 (es) 2019-02-13

Similar Documents

Publication Publication Date Title
EA201990566A1 (ru) Композиции, содержащие бактериальные штаммы
EA201790265A1 (ru) Способы получения тромбоцит-содержащих продуктов
IL273255A (en) Preparations and methods for lyophilization of bacterial strains and listeria
MY191539A (en) Streptococcal vaccine
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
MX2017016401A (es) Composiciones inmunogenas.
AR091582A1 (es) Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas
AR105287A1 (es) Desarrollo de una levadura reductora de la asparagina mediante evolución adaptiva y usos de la misma para reducir la formación de acrilamida
MX2016012372A (es) Composiciones inmunologicas que contienen histophilus somni atenuado.
EP4342545A3 (en) Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
TN2016000435A1 (en) Novel macrocyclic compounds.
PH12016502001A1 (en) Novel bacteriophage and composition comprising same
WO2021053242A3 (en) Bacteriocins for control of salmonella enterica
WO2018097712A8 (en) PROCESS FOR PREPARING A GLUCIDIC AND / OR PROTEIN PRODUCT
MX2016013277A (es) Vacuna para estreptococo de grupo a.
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
WO2016100615A3 (en) Methods and composition for neutralization of influenza
MX2018014532A (es) Un metodo para reducir la contaminacion de los huevos.
PH12015501974A1 (en) Restructured natural protein matrices
PH12017500407A1 (en) Streptococcus agalactiae antigens associated with strains virulent in fish
PH12019550183A1 (en) Treatment of infant colic
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
MX2016009094A (es) Composiciones de heme-haloperoxidasa bioactiva y sus metodos de uso.
PH12016502000B1 (en) Novel bacteriophage and composition comprising same
MX2016008884A (es) Formas solidas de tenofovir.